The U.S. Food and Drug Administration has approved bemotrizinol as a new active ingredient in sunscreens, marking the first addition to its list in about 20 years. This broad-spectrum UV filter effectively shields against both UVA and UVB rays, offering enhanced protection for users. Bemotrizinol has been used safely in Europe and Asia for decades, where it has gained recognition for its performance and low irritation potential. Its approval is expected to lead to the development of more effective sunscreen formulations available to consumers across the United States.
The decision comes after sustained efforts by dermatologists and public health advocates to modernize American sunscreen regulations and align them with global standards. With this update, manufacturers can now incorporate bemotrizinol into products, potentially improving overall sun protection. The move reflects a growing emphasis on advanced ingredients that support long-term skin health and reduce the risk of UV-related damage. Consumers may soon see a wider range of sunscreens featuring this scientifically supported compound.